Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure

Robin Altman, Sonny Ly, Silvia Hilt, Jitka Petrlova, Izumi Maezawa, T. Kalai, K. Hideg, Lee Way Jin, Ted A. Laurence, John C. Voss

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Alzheimer's disease is characterized by the presence of extracellular plaques comprised of amyloid beta (Aβ) peptides. Soluble oligomers of the Aβ peptide underlie a cascade of neuronal loss and dysfunction associated with Alzheimer's disease. Single particle analyses of Aβ oligomers in solution by fluorescence correlation spectroscopy (FCS) were used to provide real-time descriptions of how spin-labeled fluorenes (SLFs; bi-functional small molecules that block the toxicity of Aβ) prevent and disrupt oligomeric assemblies of Aβ in solution. Furthermore, the circular dichroism (CD) spectrum of untreated Aβ shows a continuous, progressive change over a 24-hour period, while the spectrum of Aβ treated with SLF remains relatively constant following initial incubation. These findings suggest the conformation of Aβ within the oligomer provides a complementary determinant of Aβ toxicity in addition to oligomer growth and size. Although SLF does not produce a dominant state of secondary structure in Aβ, it does induce a net reduction in beta secondary content compared to untreated samples of Aβ. The FCS results, combined with electron paramagnetic resonance spectroscopy and CD spectroscopy, demonstrate SLFs can inhibit the growth of Aβ oligomers and disrupt existing oligomers, while retaining Aβ as a population of smaller, yet largely disordered oligomers.

Original languageEnglish
Pages (from-to)1860-1870
Number of pages11
JournalBiochimica et Biophysica Acta - Proteins and Proteomics
Volume1854
Issue number12
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Fluorenes
Amyloid beta-Peptides
Fluorescence Spectrometry
Circular Dichroism
Oligomers
Spectrum Analysis
Alzheimer Disease
Electron Spin Resonance Spectroscopy
Growth
Peptides
Spectroscopy
Toxicity
Population
Fluorescence
Circular dichroism spectroscopy
Amyloid
Paramagnetic resonance
Conformations

Keywords

  • Amyloid beta
  • Circular dichroism spectroscopy
  • Fluorescence correlation spectroscopy
  • Oligomer
  • Secondary structure
  • Spin-labeled fluorene

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Analytical Chemistry
  • Molecular Biology

Cite this

Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure. / Altman, Robin; Ly, Sonny; Hilt, Silvia; Petrlova, Jitka; Maezawa, Izumi; Kalai, T.; Hideg, K.; Jin, Lee Way; Laurence, Ted A.; Voss, John C.

In: Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1854, No. 12, 01.12.2015, p. 1860-1870.

Research output: Contribution to journalArticle

Altman, Robin ; Ly, Sonny ; Hilt, Silvia ; Petrlova, Jitka ; Maezawa, Izumi ; Kalai, T. ; Hideg, K. ; Jin, Lee Way ; Laurence, Ted A. ; Voss, John C. / Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure. In: Biochimica et Biophysica Acta - Proteins and Proteomics. 2015 ; Vol. 1854, No. 12. pp. 1860-1870.
@article{c96a27f337414b9c9d52bf88d80dcbbb,
title = "Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure",
abstract = "Alzheimer's disease is characterized by the presence of extracellular plaques comprised of amyloid beta (Aβ) peptides. Soluble oligomers of the Aβ peptide underlie a cascade of neuronal loss and dysfunction associated with Alzheimer's disease. Single particle analyses of Aβ oligomers in solution by fluorescence correlation spectroscopy (FCS) were used to provide real-time descriptions of how spin-labeled fluorenes (SLFs; bi-functional small molecules that block the toxicity of Aβ) prevent and disrupt oligomeric assemblies of Aβ in solution. Furthermore, the circular dichroism (CD) spectrum of untreated Aβ shows a continuous, progressive change over a 24-hour period, while the spectrum of Aβ treated with SLF remains relatively constant following initial incubation. These findings suggest the conformation of Aβ within the oligomer provides a complementary determinant of Aβ toxicity in addition to oligomer growth and size. Although SLF does not produce a dominant state of secondary structure in Aβ, it does induce a net reduction in beta secondary content compared to untreated samples of Aβ. The FCS results, combined with electron paramagnetic resonance spectroscopy and CD spectroscopy, demonstrate SLFs can inhibit the growth of Aβ oligomers and disrupt existing oligomers, while retaining Aβ as a population of smaller, yet largely disordered oligomers.",
keywords = "Amyloid beta, Circular dichroism spectroscopy, Fluorescence correlation spectroscopy, Oligomer, Secondary structure, Spin-labeled fluorene",
author = "Robin Altman and Sonny Ly and Silvia Hilt and Jitka Petrlova and Izumi Maezawa and T. Kalai and K. Hideg and Jin, {Lee Way} and Laurence, {Ted A.} and Voss, {John C.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.bbapap.2015.09.002",
language = "English",
volume = "1854",
pages = "1860--1870",
journal = "Biochimica et Biophysica Acta - Proteins and Proteomics",
issn = "1570-9639",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure

AU - Altman, Robin

AU - Ly, Sonny

AU - Hilt, Silvia

AU - Petrlova, Jitka

AU - Maezawa, Izumi

AU - Kalai, T.

AU - Hideg, K.

AU - Jin, Lee Way

AU - Laurence, Ted A.

AU - Voss, John C.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Alzheimer's disease is characterized by the presence of extracellular plaques comprised of amyloid beta (Aβ) peptides. Soluble oligomers of the Aβ peptide underlie a cascade of neuronal loss and dysfunction associated with Alzheimer's disease. Single particle analyses of Aβ oligomers in solution by fluorescence correlation spectroscopy (FCS) were used to provide real-time descriptions of how spin-labeled fluorenes (SLFs; bi-functional small molecules that block the toxicity of Aβ) prevent and disrupt oligomeric assemblies of Aβ in solution. Furthermore, the circular dichroism (CD) spectrum of untreated Aβ shows a continuous, progressive change over a 24-hour period, while the spectrum of Aβ treated with SLF remains relatively constant following initial incubation. These findings suggest the conformation of Aβ within the oligomer provides a complementary determinant of Aβ toxicity in addition to oligomer growth and size. Although SLF does not produce a dominant state of secondary structure in Aβ, it does induce a net reduction in beta secondary content compared to untreated samples of Aβ. The FCS results, combined with electron paramagnetic resonance spectroscopy and CD spectroscopy, demonstrate SLFs can inhibit the growth of Aβ oligomers and disrupt existing oligomers, while retaining Aβ as a population of smaller, yet largely disordered oligomers.

AB - Alzheimer's disease is characterized by the presence of extracellular plaques comprised of amyloid beta (Aβ) peptides. Soluble oligomers of the Aβ peptide underlie a cascade of neuronal loss and dysfunction associated with Alzheimer's disease. Single particle analyses of Aβ oligomers in solution by fluorescence correlation spectroscopy (FCS) were used to provide real-time descriptions of how spin-labeled fluorenes (SLFs; bi-functional small molecules that block the toxicity of Aβ) prevent and disrupt oligomeric assemblies of Aβ in solution. Furthermore, the circular dichroism (CD) spectrum of untreated Aβ shows a continuous, progressive change over a 24-hour period, while the spectrum of Aβ treated with SLF remains relatively constant following initial incubation. These findings suggest the conformation of Aβ within the oligomer provides a complementary determinant of Aβ toxicity in addition to oligomer growth and size. Although SLF does not produce a dominant state of secondary structure in Aβ, it does induce a net reduction in beta secondary content compared to untreated samples of Aβ. The FCS results, combined with electron paramagnetic resonance spectroscopy and CD spectroscopy, demonstrate SLFs can inhibit the growth of Aβ oligomers and disrupt existing oligomers, while retaining Aβ as a population of smaller, yet largely disordered oligomers.

KW - Amyloid beta

KW - Circular dichroism spectroscopy

KW - Fluorescence correlation spectroscopy

KW - Oligomer

KW - Secondary structure

KW - Spin-labeled fluorene

UR - http://www.scopus.com/inward/record.url?scp=84944145526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944145526&partnerID=8YFLogxK

U2 - 10.1016/j.bbapap.2015.09.002

DO - 10.1016/j.bbapap.2015.09.002

M3 - Article

VL - 1854

SP - 1860

EP - 1870

JO - Biochimica et Biophysica Acta - Proteins and Proteomics

JF - Biochimica et Biophysica Acta - Proteins and Proteomics

SN - 1570-9639

IS - 12

ER -